scholarly journals Estimating the causal effects of chronic disease combinations on 30-day hospital readmissions based on observational Medicaid data

2017 ◽  
Vol 25 (6) ◽  
pp. 670-678 ◽  
Author(s):  
Sabrina Casucci ◽  
Li Lin ◽  
Sharon Hewner ◽  
Alexander Nikolaev

Abstract Objective Demonstrate how observational causal inference methods can generate insights into the impact of chronic disease combinations on patients’ 30-day hospital readmissions. Materials and Methods Causal effect estimation was used to quantify the impact of each risk factor scenario (ie, chronic disease combination) associated with chronic kidney disease and heart failure (HF) for adult Medicaid beneficiaries with initial hospitalizations in 2 New York State counties. The experimental protocol: (1) created matched risk factor and comparator groups, (2) assessed covariate balance in the matched groups, and (3) estimated causal effects and their statistical significance. Causality lattices summarized the impact of chronic disease comorbidities on readmissions. Results Chronic disease combinations were ordered with respect to their causal impact on readmissions. Of disease combinations associated with HF, the combination of HF, coronary artery disease, and tobacco abuse (in that order) had the highest causal effect on readmission rate (+22.3%); of disease combinations associated with chronic kidney disease, the combination of chronic kidney disease, coronary artery disease, and diabetes had the highest effect (+9.5%). Discussion Multi-hypothesis causal analysis reveals the effects of chronic disease comorbidities on health outcomes. Understanding these effects will guide the development of health care programs that address unique care needs of different patient subpopulations. Additionally, these insights bring new attention to individuals at high risk for readmission based on chronic disease comorbidities, allowing for more personalized attention and prioritization of care. Conclusion Multi-hypothesis causal analysis, a new methodological tool, generates meaningful insights from health care claims data, guiding the design of care and intervention programs.

2021 ◽  
Vol Volume 14 ◽  
pp. 3749-3759
Author(s):  
Raffaele Serra ◽  
Umberto Marcello Bracale ◽  
Nicola Ielapi ◽  
Luca Del Guercio ◽  
Maria Donata Di Taranto ◽  
...  

Author(s):  
Srikar Sama ◽  
Alekhya Gajjala

Routine care for chronic disease is an ongoing major challenge. We aimed to evaluate the impact of COVID-19 on routine care for chronic diseases. A deeper understanding helps to increase the health system’s resilience and adequately prepare for the next waves of the pandemic. Diabetes, heart failure, chronic kidney disease, and hypertension were the most impacted conditions due to the reduction in access to care. It is important routine care continues in spite of the pandemic, to avoid a rise in non-COVID-19-related morbidity and mortality. This is a review article discussing the potential impact of COVID-19 on chronic disease management.


2010 ◽  
Vol 55 (3) ◽  
pp. 328-336 ◽  
Author(s):  
Tatsuhiko Furuhashi ◽  
Masao Moroi ◽  
Nobuhiko Joki ◽  
Hiroki Hase ◽  
Hirofumi Masai ◽  
...  

2019 ◽  
Vol 3 (Supplement_1) ◽  
Author(s):  
Kathleen Woolf ◽  
Azizi Seixas ◽  
Alexis Moore ◽  
Collin Popp ◽  
William Coleman ◽  
...  

Abstract Objectives Sleep disturbances have been recognized as risk factors in the etiology of chronic disease and obesity. Although multifactorial, the link may be due to dietary intake, mediated by appetite hormones, hedonic feeding, altered intake times, and extended intake hours. The purpose of this study was to examine daytime sleepiness and dietary intake in overweight/obese individuals with diabetes and chronic kidney disease. Methods Three-day food records were completed at baseline from 133 participants in an ongoing lifestyle intervention study, and analyzed using the Nutrition Data System for Research (2014). Daily dietary intakes were summarized for energy (kcal), carbohydrate (g), fat (g), alcohol (g), added sugars (g), and refined grains (ounce equivalents). Self-reported measures of daytime sleepiness were measured using the Epworth Sleepiness Scale (ESS). Participants rated their level of sleepiness (scale 0–3) in eight different situations, which were summed to provide a total score. The ESS scores were dichotomized with 0–10 indicating “normal daytime sleepiness” (NDS) and 11–24 indicating “excessive daytime sleepiness” (EDS). IBM SPSS Statistics (version 25.0) was utilized to complete the descriptive and inferential analyses. Independent sample t-tests examined differences between the two sleepiness groups. Results were considered significant at p ≤ 0.05. Results The participants were 53.4% male, 89.5% non-Hispanic, 65.4% white, and 65.0 ± 9.4SD years of age with a mean body mass index of 34.0 ± 5.1SD kg/m2. Although there were no differences between sleepiness groups for fat and alcohol intakes, the EDS group reported a higher mean intake of carbohydrate (EDS: 247 ± 148SD g, NDS: 183 ± 76SD g; P = 0.048) and refined grains (EDS: 7.0 ± 6.5SD ounce, NDS: 4.2 ± 3.0SD ounce; P = 0.048). Although not statistically significant, the EDS group exhibited a trend toward having a higher energy intake (EDS: 2130 ± 1083SD kcal, NDS: 1776 ± 618SD kcal; P = 0.133) and added sugar intake (EDS: 44 ± 53SD g, NDS: 28 ± 26SD g, P = 0.179). Conclusions Similar to other reports, sleep disturbances, as noted by EDS, were associated with a higher intake of carbohydrate and refined grains. The results of this study support the role of sleep, alongside diet and physical activity, as important modifiable risk factors for chronic disease and obesity. Funding Sources National Institutes of Health (NIDDK, NINR)


2018 ◽  
Vol 69 (8) ◽  
pp. 2064-2066
Author(s):  
Mircea Munteanu ◽  
Adrian Apostol ◽  
Viviana Ivan

The aim of the present study is to investigate the prevalance of chronic kidney disease (CKD), of cardiovascular disease (CVD) and dyslipidemia in patients with diabetes mellitus (DM). We conducted a prospective, controlled study involving 420 diabetic patients (120 T1DM, 300 T2DM) and investigate the following aspects: the presence of vascular complications (stroke, coronary artery disease, peripheral artery disease), lipid profile (total cholesterol, LDL-cholesterol, HDL-cholesterol, triglycerides), kidney function (glomerular filtration rate, albuminuria), blood pressure, HbA1C. The results that in diabetic patients with CKD there is an increased prevalence of CVD and of dislipidemia. Also we noticed a negative correlation between total cholesterol level and decease in eGFR in all patients, with or without CKD.


Author(s):  
Denise Genereux ◽  
Lida Fan ◽  
Keith Brownlee

Chronic kidney disease, also referred to as end-stage renal disease (ESRD), is a prevalent and chronic condition for which treatment is necessary as a means of survival once affected individuals reach the fifth and final stage of the disease. Dialysis is a form of maintenance treatment that aids with kidney functioning once a normal kidney is damaged. There are two main types of dialysis: hemodialysis (HD) and peritoneal dialysis (PD). Each form of treatment is discussed between the patient and nephrologist and is largely dependent upon the following factors: medical condition, ability to administer treatment, supports, geographical location, access to necessary equipment/supplies, personal wishes, etc. For Indigenous Peoples who reside on remote Canadian First Nation communities, relocation is often recommended due to geographical location and limited access to both health care professionals and necessary equipment/supplies (i.e., quality of water, access to electricity/plumbing, etc). Consequently, the objective of this paper is to determine the psychosocial and somatic effects for Indigenous Peoples with ESRD if they have to relocate from remote First Nation communities to an urban centre. A review of the literature suggests that relocation to urban centres has negative implications that are worth noting: cultural isolation, alienation from family and friends, somatic issues, psychosocial issues, loss of independence and role adjustment. As a result of relocation, it is evident that the impact is profound in terms of an individuals’ mental, emotional, physical and spiritual well-being. Ensuring that adequate social support and education are available to patients and families would aid in alleviating stressors associated with managing chronic kidney disease.


Author(s):  
A Kim ◽  
Hayeon Lee ◽  
Eun-Jeong Shin ◽  
Eun-Jung Cho ◽  
Yoon-Sook Cho ◽  
...  

Inappropriate polypharmacy is likely in older adults with chronic kidney disease (CKD) owing to the considerable burden of comorbidities. We aimed to describe the impact of pharmacist-led geriatric medication management service (MMS) on the quality of medication use. This retrospective descriptive study included 95 patients who received geriatric MMS in an ambulatory care clinic in a single tertiary-care teaching hospital from May 2019 to December 2019. The average age of the patients was 74.9 ± 7.3 years; 40% of them had CKD Stage 4 or 5. Medication use quality was assessed in 87 patients. After providing MMS, the total number of medications and potentially inappropriate medications (PIMs) decreased from 13.5 ± 4.3 to 10.9 ± 3.8 and 1.6 ± 1.4 to 1.0 ± 1.2 (both p < 0.001), respectively. Furthermore, the number of patients who received three or more central nervous system-active drugs and strong anticholinergic drugs decreased. Among the 354 drug-related problems identified, “missing patient documentation” was the most common, followed by “adverse effect” and “drug not indicated.” The most frequent intervention was “therapy stopped”. In conclusion, polypharmacy and PIMs were prevalent in older adults with CKD; pharmacist-led geriatric MMS improved the quality of medication use in this population.


Sign in / Sign up

Export Citation Format

Share Document